NCT04735653Completed
The Support, Educate, Empower (SEE) Program
Support, Educate, Empower: The SEE Personalized Glaucoma Coaching Trial
Source: ClinicalTrials.gov · Last updated 3 Nov 2025
Brief summary (registry, in English)
This study will test whether the Support, Educate, Empower (SEE) personalized Glaucoma Coaching Program improves eye drop medication adherence among glaucoma patients compared to enhanced standard care in a randomized controlled clinical trial. As a secondary outcome, the study will test whether glaucoma related distress decreases among SEE program participants compared to the control group. The study hypothesis is that glaucoma patients with poor adherence who receive motivational-interviewing based counseling and personalized education from a trained non-physician glaucoma coach through the SEE Program will improve their medication adherence compared to glaucoma patients standard care enhanced by additional educational handouts.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 236 (actual)
- First submitted
- 28 Jan 2021
- Start date
- 27 Apr 2021
- Primary completion date
- 31 Jul 2024
- Lead sponsor
- University of Michigan
- Diseases
- Glaucoma
- NCT number
- NCT04735653
What you commit to
- Study type: Interventional
- Participants enrolled: 236
- From 27 Apr 2021 to the primary completion date, 31 Jul 2024
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Had laser or incisional glaucoma surgery within three months of enrollment or scheduled during the six-month study period
Other illness
- Have a diagnosed serious mental illness (for example, Schizophrenia)
- Diagnosed cognitive impairment
- Active ocular infection or uveitis
Other
- Do not speak English
- Do not instill their own eye drops
- Unable to attend all study visits
Who the study is looking for
- Taking greater or equal to 1 ocular hypotensive medication with a diagnosis of any kind of glaucoma, suspected glaucoma or ocular hypertension
- Did not opt-out from recruitment letter
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Michigan Coordinator of this site? Confirm its status | Ann Arbor | United States | Unknown status |
| Henry Ford Hospital Coordinator of this site? Confirm its status | Detroit | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.